Clinical Trial

Testing Experimental Breast Cancer Treatment

Study Description

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

The standard or usual treatment for this disease is to undergo chemotherapy to slow the spread of the disease and relieve some symptoms of cancer. Patients will have already had at least one chemotherapy treatment for their disease at this stage.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Drug - CFI-400945

Cycle 1 dose assigned at enrollment, cycle1: day 1-7, 15-21; 28 day cycle. Cycle 2 onwards (28 days duration):

Additional Information

Official Study Title

A Phase II Study of CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

Clinical Trial ID

NCT03624543

ParticipAid ID

bDkRya